Trinity Biotech (TRIB) Liabilities from Discontinued Operations (2016 - 2024)
Trinity Biotech (TRIB) posted Liabilities from Discontinued Operations of 800000.0 for Q4 2024, down 153.33% sequentially from 1500000.0 in Q4 2023, and down 153.33% YoY from 1500000.0 in Q1 2024.
Trinity Biotech (TRIB) Liabilities from Discontinued Operations (2016 - 2024) Analysis & Trends
Trinity Biotech has reported Liabilities from Discontinued Operations for 3 years, with the latest figure at 800000.0 in Q4 2024.
- Quarterly Liabilities from Discontinued Operations fell 153.33% year-over-year to 800000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 800000.0 (down 153.33% YoY) and the FY2024 annual result came in at 800000.0, down 153.33% from the prior year.
- Liabilities from Discontinued Operations slipped to 800000.0 in Q4 2024 per TRIB's latest filing, from 1500000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 1500000.0 in Q4 2023 and troughed at 800000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -800,000.00 |
| Dec 31, 2024 | -800,000.00 |
| Dec 31, 2023 | 1.50 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2016 | 3.43 Mn |
| Dec 31, 2016 | 3.43 Mn |